Facing Lung Cancer Together: A Patient and Care Partner Share Their Journey“Key Takeaways: Early detection and clinical trials are pivotal in managing small cell lung cancer, as highlighted by Wendy’s experience. A robust support system, including family and...
Dietary Glycemic Index, Glycemic Load, and Risk of Lung Cancer: A Population-Based Cohort Study“CONCLUSIONS These findings show that high dietary GI is associated with an increased risk of lung cancer, NSCLC, and SCLC, whereas GL is inversely associated with the risk...
FDA grants traditional approval to tarlatamab-dlle for extensive stage small cell lung cancer“On November 19, 2025, the Food and Drug Administration granted traditional approval to tarlatamab-dlle (Imdelltra, Amgen Inc.) for adults with extensive stage small cell lung...
A mild symptom was bothering a young dad. He had Stage IV lung cancer.“Endurance athlete Kevin Humphrey was used to discomfort. He regularly participated in ultramarathons and other intense events. Swimming, biking and running dozens of miles at a time was standard...
LUNGevity Foundation Launches 2025 Lung Cancer Awareness Month with 60,000 White Flags on the National Mall in Washington DC“WASHINGTON, Nov. 3, 2025 /PRNewswire/ — This November, during Lung Cancer Awareness Month (LCAM), LUNGevity Foundation will lead a...
The New Lung Cancer Divide: Rural, Low-Income Young Adults Left Behind“A sweeping U.S. analysis of 18,595 people aged 18–50 diagnosed with early-onset non–small cell lung cancer (NSCLC) has a blunt message: outcomes hinge not only on tumor biology but on where you...
Personalized cancer vaccines: A new frontier in lung cancer treatment and prevention“Despite declining tobacco use, lung cancer remains the leading cause of cancer-related death worldwide. As oncologists seek more-effective and individualized therapies, Mayo Clinic...
Actinium Pharmaceuticals to Unveil the Multi-Tumor Potential of ATNM-400, a First-in-Class Actinium-225 Radiotherapy, with Data in Non-Small Cell Lung Cancer at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics“ATNM-400 is...
FDA Approves Genentech’s Tecentriq Plus Lurbinectedin as First-Line Maintenance Therapy for Extensive-Stage Small Cell Lung Cancer“Combination reduced the risk of disease progression or death by 46% and risk of death by 27% in pivotal Phase III IMforte study. First...
Duke researchers discover new origin of small cell lung cancer in study“DURHAM, N.C. (WTVD) — Small cell lung cancer is one of the most aggressive and deadly forms of lung cancer commonly associated with smoking. Now, researchers at Duke Health have uncovered a...
More News and Updates